42 MULTIFUNCTIONAL INGREDIENTS A Viscosity mPa⋅s
40 35 30 25 20 15 10 5
0.5 1.0 A: % GluCPX 1.5 2.0
30000 25000 20000 15000 10000 5000 0
40 35 30 25 20 15 10 5
0.5 1.0 A: % GluCPX Figure 2: Viscosity response surface (A) and predicted stability probability (B) based on Oil and GluCPX concentrations
At 15 minutes, B was introduced, and the stirring speed was raised to 2500 rpm for 15 minutes. C was added and stirring reduced to 1500 rpm. Stirring was stopped after a total of 35 minutes. Two responses were selected to evaluate the influence of GluCPX within the experimental design space. Viscosity was measured using a Brookfield viscometer at 20 rpm after one minute of mixing. Overall emulsion stability was assessed over a period of one month at both room temperature and 40°C. Stability was determined by visual observation
and expressed as a binary response (0 or 1), where 1 indicated stability (no signs of instability such as oil separation or creaming), and 0 indicated instability. To further confirm the synergetic action of
the GluCPX blend, each individual component was tested separately in the same emulsion chassis and at concentrations equivalent to their level within the complete blend. Glucomannan alone, xanthan gum alone, PG4L alone, and the combination of xanthan gum and PG4L.
Prediction of viscosity and stability based on oil and GluCPX concentrations Emulsion viscosities, with a variable quantity of oil phase and GluCPX, ranged from 4,000 to 30,000
TABLE 1: FORMULATION TABLE OF THE EMULSION FOR THE EXPERIMENTAL DESIGN WITH VARIOUS AMOUNTS OF GLUCPX AND OIL PHASE.
Phase Ingredient A1 Water Sodium benzoate1 A2 B C
Inagel Green/GluCPX2 Glycerin1
Sweet almond oil1 DUB MCT 5545 MB3 Tocopherol4 Sepicide LD5
INCI Aqua Sodium Benzoate
Glucomannan, Capric/Caprylic Triglycerides, Polyglyceryl-4-laurate & Xanthan Gum
Glycerin
Prunus amygdalus dulcis oil Caprylic/Capric Triglycerides Tocopherol
Phenoxyethanol Suppliers: 1: Cooper 2: Inabata 3: Stearinerie Dubois 4: BASF 5: Seppic
mPas. Statistical modelling showed that viscosity is primarily driven by the concentration of GluCPX, which displays a strong and highly significant positive effect. This confirms that increasing the level of GluCPX directly enhances the viscosity of the formula. In contrast, the oil phase quantity has a comparatively no influence on viscosity under the tested conditions. The projection of the model is presented in Figure 2A. The stability model confirmed that GluCPX
plays a central role in emulsion stabilization. It showed a strong and significant contribution of
GluCPX (A); while oil concentration (B) alone had no measurable effect. However, their interaction (A:B) was significant, indicating that the stabilizing capacity of GluCPX depends on the amount of dispersed oil. This interaction reflects the well-known
challenges of stabilizing very low-oil gel-creams and high-oil emulsions, both located near formulation stability limits. The augmentation introduced in step two improved the reliability of the stability threshold, highlighting a transition from low stability probabilities below 0.5%
%
qsp 0.5
0.2-2 3
5-40%
Ratio 30/70 0.5
0.5 1.5 2.0 B
Probability of stability
100 80 60 40 20 0
Xanthan Day +1
PG4 L Day +1
Gluco Day +1
Xan+PG4L Day +1
GluCPX+6 months
Figure 3: Emulsions with 20% oil phase and 1.3% GluCPX (e) or the equivalent concentration in the blend of xanthan gum (a), polyglycerol-4-laurate (b), glucomannan (c), xanthan gum and polyglycerol-4-laurate (d); a, b, c and d present creaming and phase shifting after 24 hours. Sample e, within the stability zone Figure 2B, is stable
PERSONAL CARE MAGAZINE April 2026
www.personalcaremagazine.com
B: % Oil Phase
B: % Oil Phase
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152